Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,953,018
+$9,865,088 QoQ
Shares Held
7,417,479
+63.2% QoQ
Ownership
3.80%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#8
of 131 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. OVID ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in OVID
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,716,343 | 9,559,979 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $19,953,018 | 7,417,479 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,087,930 | 4,544,113 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $6,984,550 | 4,285,000 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $15,133,190 | 9,284,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,699 | 12,846 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,236 | 115,867 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,150 | 115,867 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $121,916 | 130,532 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $44,536 | 37,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,757 | 19,190 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $50,160 | 16,446 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,652 | 13,246 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||